H Pylori Antigen Level, Stool
Campylobacter pylori, H. pylori, gastritis, Helicobacter pylori Antigen, Stool, Helicobacter pylori Stool Antigen
Test Codes
EPIC: LAB880
Department
Immunology
Specimen Collection Criteria
Collect: Random stool specimen in a sterile collection container with no preservatives. (Minimum: 0.5 g).
Physician Office/Draw Specimen Preparation
Maintain specimen (in sterile collection container) refrigerated (2°– 8°C).
Preparation for Courier Transport
Transport: Stool in a sterile collection container, refrigerated (2°– 8°C). (Minimum: 0.5 g)
Rejection Criteria
- Rectal swabs.
- Stool specimens received in transport media or preservative.
- 24-hour collection of stool.
In-Lab Processing
- Specimen transferred to a freezer.
- Maintain specimen frozen (-20°C or below) prior to testing.
Storage
Specimen Stability for Testing:
Unpreserved:
Room Temperature (20-26°C or 68-78.8°F): Unacceptable
Refrigerated (2-8°C or 36-46°F): 72 hours
Frozen (-20°C/-4°F or below): >72 hours
Specimen Storage in Department Prior to Disposal:
Specimen retained for 72 hours after testing is completed.
Laboratory
Royal Oak Special Chemistry Laboratory
Performed
Monday, Wednesday, Friday.
Results available 3-5 days.
Reference Range
Negative for H. pylori antigen.
Test Methodology
Chemiluminescence
Interpretation
Antimicrobials, proton pump inhibitors and bismuth preparations are known to suppress H. Pylori growth. Ingestion of these agents within 2 weeks of H. Pylori antigen may produce false negative results.
Testing to confirm eradication of H. Pylori should be done four or more weeks after completion of therapy.
Clinical Utility
This assay provides a non-invasive method for the identification of Helicobacter pylori in stool. Test results are intended to aid in the diagnosis of H. pylori infection, and to monitor response during and after therapy in adult patients.
Clinical Disease
Nearly 70% of gastric ulcers and more than 90% of duodenal ulcers have been associated with H. pylori infections. H. pylori infection has also been associated with adenocarcinoma of the stomach. Nearly all patients with H. pylori have antral gastritis.
Epidemiology
Prevalence of infection increases with age. By 60 years of age, 50% of patients have evidence of H. pylori infection. Despite this high incidence, disease is seen in only a small percentage of this population (less than 2%). African Americans and Hispanics have increased infection rates over non-Hispanic Caucasians. Infection rates are higher in lower socioeconomic areas. Infection is infrequent in childhood.
Transmission
H. pylori is believed to be transmitted by the fecal-oral route. Enhanced transmission can occur in areas with overcrowded living conditions. Patients with H. pylori infection may develop acute gastritis within two weeks following infection.
Reference
- Lawson, A.J. 2011. Heliobacter. Manual of Clinical Microbiology, 10th edition. Versalovic, J. et. al. (eds.) ASM Press. Washington, D.C.
CPT Codes
87338
LOINC Code: 17780-8
Contacts
Special Chemistry Laboratory – RO
248-551-8071
Name: Special Chemistry Laboratory – RO
Location:
Phone: 248-551-8071
Last Updated
4/1/2025
Microtainer® and Vacutainer® are registered trademarks of Becton, Dickinson and Company.
UroVysion® is a registered trademark of Abbott Laboratories. ThinPrep® is a registered trademark of Hologic, Incorporated.